NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusive (the “Class Period”), of the important February 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Caribou securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem ...

SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Caribou Biosciences, Inc. (NASDAQ: CRBU) securities between July 14, 2023 and July 16, 2024. Caribou is a clinical-stage biopharmaceutical company that purports to develop genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the U.S. and internationally.For more information, submit a form, email atto ...

NEW YORK, Jan. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU).Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/caribou-biosciences-inc-loss-submission-form/?id=121489&from=4 CLASS PERIOD: Jul ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Caribou To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $75,000 in Caribou between July 14, 2023 and July 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Jan. 8, 2025 /PRNewswire/ -- F ...

NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusive (the "Class Period"), of the important February 24, 2025 lead plaintiff deadline.So what: If you purchased Caribou securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to ...

BERKELEY, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, is scheduled to present a corporate update at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 am PST. For more information and a link to the live webcast, visit the Events page on Caribou’s website. Webcasts wil ...

诉讼背景 - Caribou Biosciences公司面临集体诉讼，指控其在2023年7月14日至2024年7月16日期间存在证券欺诈行为，导致投资者遭受损失 [1] 诉讼指控 - 公司被指控夸大CB-010疗法的安全性、有效性和持久性，尤其是在治疗复发/难治性B细胞非霍奇金淋巴瘤（r/r B-NHL）和大B细胞淋巴瘤（LBCL）方面，同时夸大了其临床结果和商业前景 [2] - 公司被指控隐瞒其现金、流动性或其他资本不足的风险，可能无法支持当前的业务运营，包括与同种异体CAR-NK平台相关的临床前研究活动 [2] - 上述问题可能对公司的业务和运营产生重大负面影响 [2] - 公司被指控在相关时间内的公开声明存在重大虚假和误导性 [2] 诉讼进展 - 受影响的投资者可在2025年2月24日前申请成为首席原告，但无需担任首席原告即可参与赔偿 [3] - 符合条件的投资者可能无需支付任何费用即可获得赔偿 [3] 律所背景 - Levi & Korsinsky律所在过去20年中为受损股东争取了数亿美元的赔偿，并在高风险的证券诉讼中建立了良好的记录 [4] - 该律所拥有超过70名员工，连续七年被ISS Securities Class Action Services评为美国顶级证券诉讼律所之一 [4]

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Caribou securities between July 14, 2023 and July 16, 2024, both dates inclusive (the “Class Period”). In ...

NEW YORK, Jan. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU).Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/caribou-biosciences-inc-loss-submission-form/?id=120465&from=4CLASS PERIOD: July ...

NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, Inc." or the "Company") (NASDAQ: CRBU) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Caribou Biosciences, Inc. investors who were adversely affected by alleged securities fraud between July 14, 2023 and July 16, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/p ...